Trastorno obsesivo-compulsivo en niños y adolescentes: una revisión del tratamiento

Content Provider	Semantic Scholar
Author	Flores, Rosa Elena Ulloa Cruz, Lino Palacios Vera, Tizbé Del Rosario Sauer
Copyright Year	2011
Abstract	SUMMARY Obsessive-compulsive disorder (OCD) in children and adolescents is a chronic disease with poor prognosis. This article includes recommendations for the assessment and multidisciplinary treatment of pediatric patients with OCD, which includes education, pharmacological and psychotherapeutic interventions. The evaluation must include rating scales for the severity and functional impairment, such as the Yale Brown Scale and the Child Obsessive-Compulsive Impact Scale. Drug treatment is based on serotonin reuptake inhibitors (SRIs). The Food and Drug Administration approved clomipramine (CMI), sertraline, fluvoxamine and fluoxetine in this age group. Although CMI has a superior effect size than the SRIs, side effects have limited its use as a first choice. Rulizole, a glutamate antagonist, has shown tolerability and efficacy as adjunctive therapy. Comorbidity, particularly with externalizing disorders, can moderate the treatment response, thus the addition of other drugs should be considered. Psychoeducation is aimed at improving the knowledge about the illness and improving
Starting Page	415
Ending Page	420
Page Count	6
File Format	PDF HTM / HTML
Volume Number	34
Alternate Webpage(s)	http://www.medigraphic.com/pdfs/salmen/sam-2011/sam115c.pdf
Alternate Webpage(s)	http://www.scielo.org.mx/pdf/sm/v34n5/v34n5a4.pdf
Language	English
Access Restriction	Open
Content Type	Text
Resource Type	Article